Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Drug-Resistant Tuberculosis Treatment
1.2 Key Market Segments
1.2.1 Drug-Resistant Tuberculosis Treatment Segment by Type
1.2.2 Drug-Resistant Tuberculosis Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Drug-Resistant Tuberculosis Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Drug-Resistant Tuberculosis Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Drug-Resistant Tuberculosis Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Drug-Resistant Tuberculosis Treatment Market Competitive Landscape
3.1 Global Drug-Resistant Tuberculosis Treatment Sales by Manufacturers (2019-2024)
3.2 Global Drug-Resistant Tuberculosis Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Drug-Resistant Tuberculosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Drug-Resistant Tuberculosis Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Drug-Resistant Tuberculosis Treatment Sales Sites, Area Served, Product Type
3.6 Drug-Resistant Tuberculosis Treatment Market Competitive Situation and Trends
3.6.1 Drug-Resistant Tuberculosis Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Drug-Resistant Tuberculosis Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Drug-Resistant Tuberculosis Treatment Industry Chain Analysis
4.1 Drug-Resistant Tuberculosis Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Drug-Resistant Tuberculosis Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Drug-Resistant Tuberculosis Treatment Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug-Resistant Tuberculosis Treatment Sales Market Share by Type (2019-2024)
6.3 Global Drug-Resistant Tuberculosis Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Drug-Resistant Tuberculosis Treatment Price by Type (2019-2024)
7 Drug-Resistant Tuberculosis Treatment Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug-Resistant Tuberculosis Treatment Market Sales by Application (2019-2024)
7.3 Global Drug-Resistant Tuberculosis Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Drug-Resistant Tuberculosis Treatment Sales Growth Rate by Application (2019-2024)
8 Drug-Resistant Tuberculosis Treatment Market Segmentation by Region
8.1 Global Drug-Resistant Tuberculosis Treatment Sales by Region
8.1.1 Global Drug-Resistant Tuberculosis Treatment Sales by Region
8.1.2 Global Drug-Resistant Tuberculosis Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Drug-Resistant Tuberculosis Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Drug-Resistant Tuberculosis Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Drug-Resistant Tuberculosis Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Drug-Resistant Tuberculosis Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Drug-Resistant Tuberculosis Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Sanofi
9.1.1 Sanofi Drug-Resistant Tuberculosis Treatment Basic Information
9.1.2 Sanofi Drug-Resistant Tuberculosis Treatment Product Overview
9.1.3 Sanofi Drug-Resistant Tuberculosis Treatment Product Market Performance
9.1.4 Sanofi Business Overview
9.1.5 Sanofi Drug-Resistant Tuberculosis Treatment SWOT Analysis
9.1.6 Sanofi Recent Developments
9.2 Novartis AG
9.2.1 Novartis AG Drug-Resistant Tuberculosis Treatment Basic Information
9.2.2 Novartis AG Drug-Resistant Tuberculosis Treatment Product Overview
9.2.3 Novartis AG Drug-Resistant Tuberculosis Treatment Product Market Performance
9.2.4 Novartis AG Business Overview
9.2.5 Novartis AG Drug-Resistant Tuberculosis Treatment SWOT Analysis
9.2.6 Novartis AG Recent Developments
9.3 Endo International plc
9.3.1 Endo International plc Drug-Resistant Tuberculosis Treatment Basic Information
9.3.2 Endo International plc Drug-Resistant Tuberculosis Treatment Product Overview
9.3.3 Endo International plc Drug-Resistant Tuberculosis Treatment Product Market Performance
9.3.4 Endo International plc Drug-Resistant Tuberculosis Treatment SWOT Analysis
9.3.5 Endo International plc Business Overview
9.3.6 Endo International plc Recent Developments
9.4 CMP Pharma
9.4.1 CMP Pharma Drug-Resistant Tuberculosis Treatment Basic Information
9.4.2 CMP Pharma Drug-Resistant Tuberculosis Treatment Product Overview
9.4.3 CMP Pharma Drug-Resistant Tuberculosis Treatment Product Market Performance
9.4.4 CMP Pharma Business Overview
9.4.5 CMP Pharma Recent Developments
9.5 STI Pharma LLC
9.5.1 STI Pharma LLC Drug-Resistant Tuberculosis Treatment Basic Information
9.5.2 STI Pharma LLC Drug-Resistant Tuberculosis Treatment Product Overview
9.5.3 STI Pharma LLC Drug-Resistant Tuberculosis Treatment Product Market Performance
9.5.4 STI Pharma LLC Business Overview
9.5.5 STI Pharma LLC Recent Developments
9.6 Akorn Incorporated
9.6.1 Akorn Incorporated Drug-Resistant Tuberculosis Treatment Basic Information
9.6.2 Akorn Incorporated Drug-Resistant Tuberculosis Treatment Product Overview
9.6.3 Akorn Incorporated Drug-Resistant Tuberculosis Treatment Product Market Performance
9.6.4 Akorn Incorporated Business Overview
9.6.5 Akorn Incorporated Recent Developments
9.7 Lupin
9.7.1 Lupin Drug-Resistant Tuberculosis Treatment Basic Information
9.7.2 Lupin Drug-Resistant Tuberculosis Treatment Product Overview
9.7.3 Lupin Drug-Resistant Tuberculosis Treatment Product Market Performance
9.7.4 Lupin Business Overview
9.7.5 Lupin Recent Developments
9.8 Johnson and Johnson Services Inc.
9.8.1 Johnson and Johnson Services Inc. Drug-Resistant Tuberculosis Treatment Basic Information
9.8.2 Johnson and Johnson Services Inc. Drug-Resistant Tuberculosis Treatment Product Overview
9.8.3 Johnson and Johnson Services Inc. Drug-Resistant Tuberculosis Treatment Product Market Performance
9.8.4 Johnson and Johnson Services Inc. Business Overview
9.8.5 Johnson and Johnson Services Inc. Recent Developments
9.9 Macleods Pharmaceuticals Ltd
9.9.1 Macleods Pharmaceuticals Ltd Drug-Resistant Tuberculosis Treatment Basic Information
9.9.2 Macleods Pharmaceuticals Ltd Drug-Resistant Tuberculosis Treatment Product Overview
9.9.3 Macleods Pharmaceuticals Ltd Drug-Resistant Tuberculosis Treatment Product Market Performance
9.9.4 Macleods Pharmaceuticals Ltd Business Overview
9.9.5 Macleods Pharmaceuticals Ltd Recent Developments
9.10 Pfizer Inc
9.10.1 Pfizer Inc Drug-Resistant Tuberculosis Treatment Basic Information
9.10.2 Pfizer Inc Drug-Resistant Tuberculosis Treatment Product Overview
9.10.3 Pfizer Inc Drug-Resistant Tuberculosis Treatment Product Market Performance
9.10.4 Pfizer Inc Business Overview
9.10.5 Pfizer Inc Recent Developments
9.11 Hikma Pharmaceuticals PLC
9.11.1 Hikma Pharmaceuticals PLC Drug-Resistant Tuberculosis Treatment Basic Information
9.11.2 Hikma Pharmaceuticals PLC Drug-Resistant Tuberculosis Treatment Product Overview
9.11.3 Hikma Pharmaceuticals PLC Drug-Resistant Tuberculosis Treatment Product Market Performance
9.11.4 Hikma Pharmaceuticals PLC Business Overview
9.11.5 Hikma Pharmaceuticals PLC Recent Developments
9.12 Lannett
9.12.1 Lannett Drug-Resistant Tuberculosis Treatment Basic Information
9.12.2 Lannett Drug-Resistant Tuberculosis Treatment Product Overview
9.12.3 Lannett Drug-Resistant Tuberculosis Treatment Product Market Performance
9.12.4 Lannett Business Overview
9.12.5 Lannett Recent Developments
9.13 Mylan N.V.
9.13.1 Mylan N.V. Drug-Resistant Tuberculosis Treatment Basic Information
9.13.2 Mylan N.V. Drug-Resistant Tuberculosis Treatment Product Overview
9.13.3 Mylan N.V. Drug-Resistant Tuberculosis Treatment Product Market Performance
9.13.4 Mylan N.V. Business Overview
9.13.5 Mylan N.V. Recent Developments
9.14 Teva Pharmaceutical Industries Ltd
9.14.1 Teva Pharmaceutical Industries Ltd Drug-Resistant Tuberculosis Treatment Basic Information
9.14.2 Teva Pharmaceutical Industries Ltd Drug-Resistant Tuberculosis Treatment Product Overview
9.14.3 Teva Pharmaceutical Industries Ltd Drug-Resistant Tuberculosis Treatment Product Market Performance
9.14.4 Teva Pharmaceutical Industries Ltd Business Overview
9.14.5 Teva Pharmaceutical Industries Ltd Recent Developments
9.15 Fresenius Kabi AG
9.15.1 Fresenius Kabi AG Drug-Resistant Tuberculosis Treatment Basic Information
9.15.2 Fresenius Kabi AG Drug-Resistant Tuberculosis Treatment Product Overview
9.15.3 Fresenius Kabi AG Drug-Resistant Tuberculosis Treatment Product Market Performance
9.15.4 Fresenius Kabi AG Business Overview
9.15.5 Fresenius Kabi AG Recent Developments
10 Drug-Resistant Tuberculosis Treatment Market Forecast by Region
10.1 Global Drug-Resistant Tuberculosis Treatment Market Size Forecast
10.2 Global Drug-Resistant Tuberculosis Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Drug-Resistant Tuberculosis Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Drug-Resistant Tuberculosis Treatment Market Size Forecast by Region
10.2.4 South America Drug-Resistant Tuberculosis Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Drug-Resistant Tuberculosis Treatment by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Drug-Resistant Tuberculosis Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Drug-Resistant Tuberculosis Treatment by Type (2025-2030)
11.1.2 Global Drug-Resistant Tuberculosis Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Drug-Resistant Tuberculosis Treatment by Type (2025-2030)
11.2 Global Drug-Resistant Tuberculosis Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Drug-Resistant Tuberculosis Treatment Sales (Kilotons) Forecast by Application
11.2.2 Global Drug-Resistant Tuberculosis Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
